Click for best price
Anti?vascular Endothelial Growth Factor Therapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Anti?vascular Endothelial Growth Factor Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti?vascular Endothelial Growth Factor Therapy. This report contains market size and forecasts of Anti?vascular Endothelial Growth Factor Therapy in global, including the following market information:
Global Anti?vascular Endothelial Growth Factor Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Anti?vascular Endothelial Growth Factor Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Extraction Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti?vascular Endothelial Growth Factor Therapy include Regeneron Pharmaceuticals (Eylea), Genentech and Kanghong Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti?vascular Endothelial Growth Factor Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti?vascular Endothelial Growth Factor Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Anti?vascular Endothelial Growth Factor Therapy Market Segment Percentages, by Type, 2022 (%)
Extraction Injection
Precharge Injection
Global Anti?vascular Endothelial Growth Factor Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Anti?vascular Endothelial Growth Factor Therapy Market Segment Percentages, by Application, 2022 (%)
Macular Degeneration
Nacular Edema
Uveitis
Retinal Vein Occlusion
Global Anti?vascular Endothelial Growth Factor Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Anti?vascular Endothelial Growth Factor Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti?vascular Endothelial Growth Factor Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti?vascular Endothelial Growth Factor Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Regeneron Pharmaceuticals (Eylea)
Genentech
Kanghong Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti?vascular Endothelial Growth Factor Therapy, market overview.
Chapter 2: Global Anti?vascular Endothelial Growth Factor Therapy market size in revenue.
Chapter 3: Detailed analysis of Anti?vascular Endothelial Growth Factor Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti?vascular Endothelial Growth Factor Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti?vascular Endothelial Growth Factor Therapy Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti?vascular Endothelial Growth Factor Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti?vascular Endothelial Growth Factor Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti?vascular Endothelial Growth Factor Therapy Overall Market Size
2.1 Global Anti?vascular Endothelial Growth Factor Therapy Market Size: 2022 VS 2030
2.2 Global Anti?vascular Endothelial Growth Factor Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti?vascular Endothelial Growth Factor Therapy Players in Global Market
3.2 Top Global Anti?vascular Endothelial Growth Factor Therapy Companies Ranked by Revenue
3.3 Global Anti?vascular Endothelial Growth Factor Therapy Revenue by Companies
3.4 Top 3 and Top 5 Anti?vascular Endothelial Growth Factor Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti?vascular Endothelial Growth Factor Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti?vascular Endothelial Growth Factor Therapy Players in Global Market
3.6.1 List of Global Tier 1 Anti?vascular Endothelial Growth Factor Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti?vascular Endothelial Growth Factor Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti?vascular Endothelial Growth Factor Therapy Market Size Markets, 2022 & 2030
4.1.2 Extraction Injection
4.1.3 Precharge Injection
4.2 By Type - Global Anti?vascular Endothelial Growth Factor Therapy Revenue & Forecasts
4.2.1 By Type - Global Anti?vascular Endothelial Growth Factor Therapy Revenue, 2018-2023
4.2.2 By Type - Global Anti?vascular Endothelial Growth Factor Therapy Revenue, 2024-2030
4.2.3 By Type - Global Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti?vascular Endothelial Growth Factor Therapy Market Size, 2022 & 2030
5.1.2 Macular Degeneration
5.1.3 Nacular Edema
5.1.4 Uveitis
5.1.5 Retinal Vein Occlusion
5.2 By Application - Global Anti?vascular Endothelial Growth Factor Therapy Revenue & Forecasts
5.2.1 By Application - Global Anti?vascular Endothelial Growth Factor Therapy Revenue, 2018-2023
5.2.2 By Application - Global Anti?vascular Endothelial Growth Factor Therapy Revenue, 2024-2030
5.2.3 By Application - Global Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Anti?vascular Endothelial Growth Factor Therapy Market Size, 2022 & 2030
6.2 By Region - Global Anti?vascular Endothelial Growth Factor Therapy Revenue & Forecasts
6.2.1 By Region - Global Anti?vascular Endothelial Growth Factor Therapy Revenue, 2018-2023
6.2.2 By Region - Global Anti?vascular Endothelial Growth Factor Therapy Revenue, 2024-2030
6.2.3 By Region - Global Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Anti?vascular Endothelial Growth Factor Therapy Revenue, 2018-2030
6.3.2 US Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.3.3 Canada Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.3.4 Mexico Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Anti?vascular Endothelial Growth Factor Therapy Revenue, 2018-2030
6.4.2 Germany Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.4.3 France Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.4.4 U.K. Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.4.5 Italy Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.4.6 Russia Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.4.8 Benelux Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Anti?vascular Endothelial Growth Factor Therapy Revenue, 2018-2030
6.5.2 China Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.5.3 Japan Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.5.4 South Korea Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.5.6 India Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Anti?vascular Endothelial Growth Factor Therapy Revenue, 2018-2030
6.6.2 Brazil Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.6.3 Argentina Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti?vascular Endothelial Growth Factor Therapy Revenue, 2018-2030
6.7.2 Turkey Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.7.3 Israel Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
6.7.5 UAE Anti?vascular Endothelial Growth Factor Therapy Market Size, 2018-2030
7 Anti?vascular Endothelial Growth Factor Therapy Companies Profiles
7.1 Regeneron Pharmaceuticals (Eylea)
7.1.1 Regeneron Pharmaceuticals (Eylea) Company Summary
7.1.2 Regeneron Pharmaceuticals (Eylea) Business Overview
7.1.3 Regeneron Pharmaceuticals (Eylea) Anti?vascular Endothelial Growth Factor Therapy Major Product Offerings
7.1.4 Regeneron Pharmaceuticals (Eylea) Anti?vascular Endothelial Growth Factor Therapy Revenue in Global Market (2018-2023)
7.1.5 Regeneron Pharmaceuticals (Eylea) Key News & Latest Developments
7.2 Genentech
7.2.1 Genentech Company Summary
7.2.2 Genentech Business Overview
7.2.3 Genentech Anti?vascular Endothelial Growth Factor Therapy Major Product Offerings
7.2.4 Genentech Anti?vascular Endothelial Growth Factor Therapy Revenue in Global Market (2018-2023)
7.2.5 Genentech Key News & Latest Developments
7.3 Kanghong Pharmaceutical
7.3.1 Kanghong Pharmaceutical Company Summary
7.3.2 Kanghong Pharmaceutical Business Overview
7.3.3 Kanghong Pharmaceutical Anti?vascular Endothelial Growth Factor Therapy Major Product Offerings
7.3.4 Kanghong Pharmaceutical Anti?vascular Endothelial Growth Factor Therapy Revenue in Global Market (2018-2023)
7.3.5 Kanghong Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti?vascular Endothelial Growth Factor Therapy Market Opportunities & Trends in Global Market
Table 2. Anti?vascular Endothelial Growth Factor Therapy Market Drivers in Global Market
Table 3. Anti?vascular Endothelial Growth Factor Therapy Market Restraints in Global Market
Table 4. Key Players of Anti?vascular Endothelial Growth Factor Therapy in Global Market
Table 5. Top Anti?vascular Endothelial Growth Factor Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti?vascular Endothelial Growth Factor Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti?vascular Endothelial Growth Factor Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti?vascular Endothelial Growth Factor Therapy Product Type
Table 9. List of Global Tier 1 Anti?vascular Endothelial Growth Factor Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti?vascular Endothelial Growth Factor Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Anti?vascular Endothelial Growth Factor Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti?vascular Endothelial Growth Factor Therapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Anti?vascular Endothelial Growth Factor Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti?vascular Endothelial Growth Factor Therapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Anti?vascular Endothelial Growth Factor Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti?vascular Endothelial Growth Factor Therapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2024-2030
Table 30. Regeneron Pharmaceuticals (Eylea) Company Summary
Table 31. Regeneron Pharmaceuticals (Eylea) Anti?vascular Endothelial Growth Factor Therapy Product Offerings
Table 32. Regeneron Pharmaceuticals (Eylea) Anti?vascular Endothelial Growth Factor Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Regeneron Pharmaceuticals (Eylea) Key News & Latest Developments
Table 34. Genentech Company Summary
Table 35. Genentech Anti?vascular Endothelial Growth Factor Therapy Product Offerings
Table 36. Genentech Anti?vascular Endothelial Growth Factor Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Genentech Key News & Latest Developments
Table 38. Kanghong Pharmaceutical Company Summary
Table 39. Kanghong Pharmaceutical Anti?vascular Endothelial Growth Factor Therapy Product Offerings
Table 40. Kanghong Pharmaceutical Anti?vascular Endothelial Growth Factor Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Kanghong Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Anti?vascular Endothelial Growth Factor Therapy Segment by Type in 2022
Figure 2. Anti?vascular Endothelial Growth Factor Therapy Segment by Application in 2022
Figure 3. Global Anti?vascular Endothelial Growth Factor Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti?vascular Endothelial Growth Factor Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Anti?vascular Endothelial Growth Factor Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti?vascular Endothelial Growth Factor Therapy Revenue in 2022
Figure 8. By Type - Global Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2018-2030
Figure 16. US Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2018-2030
Figure 20. Germany Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. France Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2018-2030
Figure 28. China Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. India Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2018-2030
Figure 34. Brazil Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Anti?vascular Endothelial Growth Factor Therapy Revenue Market Share, 2018-2030
Figure 37. Turkey Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Anti?vascular Endothelial Growth Factor Therapy Revenue, (US$, Mn), 2018-2030
Figure 41. Regeneron Pharmaceuticals (Eylea) Anti?vascular Endothelial Growth Factor Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Genentech Anti?vascular Endothelial Growth Factor Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Kanghong Pharmaceutical Anti?vascular Endothelial Growth Factor Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
